Chickens | | |
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline. (Feed continuously for 7 - 14 days) | 100-200 g/ton | 2.0 – 4.0 |
WARNING: DO NOT FEED TO CHICKENS PRODUCING EGGS FOR HUMAN CONSUMPTION. ZERO-DAY WITHDRAWAL PERIOD. | | |
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline. (Feed continuously for 7 - 14 days). | 200-400 g/ton | 4.0 – 8.0 |
WARNING: DO NOT FEED TO CHICKENS PRODUCING EGGS FOR HUMAN CONSUMPTION. ZERO-DAY WITHDRAWAL PERIOD. | | |
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline (Feed for 5 days). | 500 g/ton | 10.0 |
WARNING: DO NOT FEED TO CHICKENS PRODUCING EGGS FOR HUMAN CONSUMPTION. WITHDRAW 24 HOURS PRIOR TO SLAUGHTER. | | |
|
Turkeys |
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline (Feed continuously for 7 - 14 days) | 200 g/ton | 4.0 |
WARNING: DO NOT FEED TO TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION. ZERO-DAY WITHDRAWAL PERIOD. | | |
For Turkeys: Control of hexamitiasis caused by Hexamita meleagrides susceptible to chlortetracycline. (Feed continuously for 7 - 14 days). | 400 g/ton | 8.0 |
WARNING: DO NOT FEED TO TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION. ZERO-DAY WITHDRAWAL PERIOD. | | |
For Turkeys: Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline. | 400 g/ton | 8.0 |
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline. (Feed continuously for 7 - 14 days) | 25 mg/lb body weight/day |
WARNING: DO NOT FEED TO TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION. ZERO-DAY WITHDRAWAL PERIOD. | | |
|
Swine |
For Swine: Reducing the incidence of cervical lymphadenitis (jowl abscesses) caused by Group E Streptococci susceptible to chlortetracycline. | 50-100 g/ton | 1.0 – 2.0 |
For Breeding Swine: Control of leptospirosis (reducing the instances of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline. (Feed continuously for not more than 14 days) | 400 g/ton | 8.0 |
For Swine: Treatment of bacterial enteritis caused by Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Feed for not more than 14 days.) | Feed approximately 400 g/ton, varying with body weight and feed consumption to provide 10 mg/lb body weight/ day. |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |
|
CALVES, BEEF CATTLE, AND NONLACTATING DAIRY CATTLE | | |
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRE-RUMINATNG CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. | | |
For Growing cattle (over 400 lbs.): For the reduction of the incidence of liver abscesses. | 70 mg/head/day |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |
For Beef Cattle: For the control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline | 350 mg/head/day |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |
For Beef cattle (under 700 lbs.): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. | 350 mg/head/day |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |
For Beef cattle (over 700 lbs.): Control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline. | 0.5 mg/ lb. body weight/day |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |
For Calves, Beef, and Nonlactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Treat for not more than 5 days) | 10 mg/lb. body weight/day |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |
|
Sheep |
For Breeding Sheep: Reducing the incidence of (vibrionic) abortion caused by Campylobacter fetus infections susceptible to chlortetracycline. | 80 mg/head/day |
WARNING: ZERO-DAY WITHDRAWAL PERIOD. | | |